Investing Profile

Sander Slootweg

InvestorVC
Co-owner and Managing Partner at Forbion
forbion.comNetherlands
Photo of Sander Slootweg, Managing Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Forbion Managing Partner
$100K - $5.0M
$1.5M
6
CompanyStageDateRound SizeTotal Raised
NorthSea Therapeutics
Series CDec 2021$80M
Series BJan 2020$40M
Series ADec 2017$29M
$150M
Co-investors: Rob de Ree (BGV (BioGeneration Ventures)), Marco Boorsma (Forbion), Oscar Slotboom (BGV (BioGeneration Ventures)), Dirk Kersten (Forbion)
New Amsterdam Pharma
Series AJan 2021$190M
$190M
Co-investors: Peter Thiel (Founders Fund), Gaurav Gupta (Ascendant BioCapital)
Azafaros
Series AFeb 2020$27M
$27M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures))
Oxyrane UK
Series DNov 2011$27M
$27M